Wright Medical Group (WMGI) Posts Q4 Loss of $0.29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Wright Medical (WMGI) PT Raised to $31 at BMO Capital Following Strong 4Q Results
February 22, 2017 8:59 AM ESTBMO Capital Markets analyst Joanne Wuensch reiterates Outperform rating and raises price target on Wright Medical Group NV (NASDAQ: WMGI) to $31 (from 427), suggesting a positive outlook, as the company reported 2016 fourth quarter revenues and EPS above consensus, offering 2017 guidance above consensus estimates.
Wuensch... More
Jefferies Reiterates Buy on Wright Medical Group (WMGI) Following 4Q
February 22, 2017 7:14 AM ESTJefferies reiterated a Buy rating and $30.00 price target on Wright Medical Group (NASDAQ: WMGI) following the company's 4Q earnings report.
Analyst Raj Denhoy commented, "4Q was positive on numerous fronts: +15% underlying sales growth driven by Shoulders, Biologic, and Ankles; 11.7% EBITDA margins, a new high... More
Needham & Company Maintains Hold Rating on Wright Medical Group (WMGI) Following Strong 4Q16 Results
February 22, 2017 6:26 AM ESTNeedham and & Company analyst Mike Matson reiterates Hold rating on Wright Medical Group NV (NASDAQ: WMGI), as the company delivered 2016 fourth quarter revenue and EBITDA above consensus, while offering 2017 revenue guidance above consensus projections.
Matson comments, "WMGI's 4Q16 revenue and EBITDA beat consensus, and... More
